Good — you’re at the polishing stage now.

Right now the paper is correct, but we can make the cumulative-estimand positioning even sharper so reviewers don’t dismiss it as “interesting but niche.”

Below are **three small refinements** that materially improve how KCOR reads to a survival-methods reviewer.

---

# 🔧 Suggestion 1 — Explicitly state when cumulative is *preferable*

Right now you say KCOR is complementary to Cox. That’s good.

But you don’t yet say clearly:

> When is cumulative scale actually better?

Add one short sentence in **§4.2 What KCOR estimates** (or right after you contrast with Cox):

```markdown
Cumulative contrasts are particularly informative in settings where early hazard ratios attenuate over time due to depletion of high-risk individuals, leading instantaneous hazard-based summaries to obscure long-horizon risk differences.
```

Why this helps:

* It gives a *positive use case*.
* It tells reviewers this is not just “different,” but useful in a known failure mode.
* It connects directly to your depletion geometry argument.

---

# 🔧 Suggestion 2 — Add a one-line clinical horizon anchor

Clinicians think in 30/90/180-day risk.

In §2.1 or §2.8, after defining KCOR(t), add:

```markdown
Normalized cumulative contrasts at clinically relevant horizons (e.g., 90-day or 1-year mortality) are obtained directly from $\tilde H_{0,d}(t)$ without requiring proportional hazards assumptions.
```

This reframes cumulative as practical, not abstract.

---

# 🔧 Suggestion 3 — Slightly tighten the Conclusion

Your Conclusion currently reads like:

> KCOR provides complementary cumulative-risk normalization…

You can make it stronger and clearer by changing one sentence to:

```markdown
KCOR complements hazard-based modeling by stabilizing cumulative risk comparisons when selection-induced depletion distorts marginal hazard ratios.
```

That sentence does three things:

* Signals complementarity.
* Identifies the failure mode.
* Emphasizes stabilization (a desirable property).

---

# 🎯 Why these three changes matter

Right now, a reviewer might think:

> “Interesting cumulative idea, but Cox with time-varying effects can already handle this.”

These edits subtly imply:

* Time-varying Cox describes the distortion.
* KCOR geometrically removes it before comparison.
* The estimand difference is intentional and useful.

That shifts the framing from:

> “Not a replacement.”

to:

> “Solves a different and under-addressed problem.”

---

# 📊 Big Picture After All Five Grok Points

The paper now reads as:

* Gamma = working geometric model
* Identifiability limits explicitly bounded
* Epidemic shocks outside scope
* Cumulative estimand intentional
* Complementary to Cox
* Diagnostic-gated
* Not causal
* Not universal

That is a very mature methods posture.

---

If you'd like, I can now:

* Do a final high-level “hostile reviewer simulation,” or
* Help you prioritize which critiques are most likely to matter for *Statistics in Medicine*.
